 |
|
АкушерствоАнатомияАнестезиологияВакцинопрофилактикаВалеологияВетеринарияГигиенаЗаболеванияИммунологияКардиологияНеврологияНефрологияОнкологияОториноларингологияОфтальмологияПаразитологияПедиатрияПервая помощьПсихиатрияПульмонологияРеанимацияРевматологияСтоматологияТерапияТоксикологияТравматологияУрологияФармакологияФармацевтикаФизиотерапияФтизиатрияХирургияЭндокринологияЭпидемиология |
ЗАКЛЮЧЕНИЕ. Расстройства дыхания в период сна имеют разнообразные клинические симптомы
Расстройства дыхания в период сна имеют разнообразные клинические симптомы. Наиболее распространенными из них являются ощущение неосвежающего сна, избыточная дневная сонливость и утомляемость, когнитивные расстройства. В настоящее время существует все больше доказательств того, что расстройства дыхания в период сна приводят к развитию часто встречающихся сердечнососудистых осложнений и метаболических расстройств, включая системную артериальную гипертензию, нарушения функции сердца, а также резистентность к инсулину. Самым распространенным дыхательным расстройством в период сна является обструктивное апноэ сна, для лечения которого назначается чрезмасочная СРАРтерапия в период сна. Центральное апноэ сна может развиваться в виде самостоятельного расстройства или в сочетании с центральными нарушениями дыхания в период бодрствования, сопровождающимися гиповентиляцией. Чаще всего центральное апноэ сна сочетается с периодическим дыханием (дыхание Чейна - Стокса), особенно у пациентов с застойной сердечной недостаточностью. Центральное апноэ сна способно вызывать ухудшение функции миокарда и усиливать прогрессирование заболевания. Чрезмасочная СРАРтерапия является эффективным методом лечения центрального апноэ сна, в том числе она может оказывать положительное воздействие на функцию сердца у больных с синдромом Чейна - Стокса. СПИСОК ЛИТЕРАТУРЫ 1.Aserinsky E, Kleitman N: Regularly occurring periods of eye motility, and concomitant phenomena, during sleep. Science 118:273-274, 1953. 2.Dement WC, Kleitman N: Cyclic variations in EEG during sleep and their relation to eye movements, body motility, and dreaming. Electroencephalogr Clin Neurophysiol 9:673-690, 1957. 3.Jouvet M: Neurophysiology of the sleep states. Physiol Rev 47:117-177, 1967. 4.Rechtschaffen A, Kales A: A Manual of Standardized Terminology: Techniques and Scoring System for Sleep Stages of Human Subjects (Publication No. 204). Washington, DC: National Institutes of Health, 1968. 5.Phillipson EA, Bowes G: Control of breathing during sleep. In Cherniack NS, Widdicombe JG (eds): Handbook of Physiology. Section 3: The Respiratory System. Vol II: Control of Breathing (Part 2). Bethesda, Md: American Physiological Society, 1986, pp 649-689. 6.Morrell MJ, Dempsey JA: Impact of sleep on ventilation. In McNicholas WT, Phillipson EA (eds): Breathing Disorders in Sleep. London: WB Saunders, 2002, pp 3-17. 7.Horner RL: Motor control of the pharyngeal musculature and implications for the pathogenesis of obstructive sleep apnea. Sleep 19:827-853, 1996. 8.White DP, Weil JV, Zwillich CW: Metabolic rate and breathing during sleep. J Appl Physiol 59:384-391, 1985. 9.Somers VK, Dyken ME, Mark AL, et al: Sympathetic-nerve activity during sleep in normal subjects. N Engl J Med 328:303-307, 1993. 10.Shepard JW Jr: Gas exchange and hemodynamics during sleep. Med Clin North Am 69:1243-1264, 1985. 11.Hornyak M, Cejnar M, Elam M, et al: Sympathetic muscle nerve activity during sleep in man. Brain 114:1281-1295, 1991. 12.Davies RJ, Belt PJ, Roberts SJ, et al: Arterial blood pressure responses to graded transient arousal from sleep in normal humans. J Appl Physiol 74:1123-1130, 1993. 13.Bowes G, Phillipson EA: Arousal responses to respiratory stimuli during sleep. In Saunders NA, Sullivan CE (eds): Lung Biology in Health and Disease. Vol 21: Sleep and Breathing. New York: Marcel Dekker, 1984, pp 137-161. 14.Stradling JR, Phillipson EA: Breathing disorders during sleep. Q J Med 58:3-18, 1986. 15.Motta J, Guilleminault C, Schroeder JS, et al: Tracheostomy and hemodynamic changes in sleep-induced apnea. Ann Intern Med 89:454-458, 1978. 16.Coleman RM: Periodic movements in sleep (nocturnal myoclonus) and restless legs syndrome. In Guilleminault C (ed): Sleep and Waking Disorders: Indications and Techniques. Menlo Park, Calif: Addison-Wesley, 1982, pp 265-295. 17.Phillipson EA, Bowes G: Sleep disorders. In Fishman AP (ed): Update of Pulmonary Diseases and Disorders. New York: McGraw-Hill, 1982, pp 256-273. 18.Stradling JR, Chadwick GA, Quirk C, et al: Respiratory inductance plethysmography: Calibration techniques, their validation and the effects of posture. Bull Eur Physiopathol Respir 21:317-324, 1985. 19.Staats BA, Bonekat HW, Harris CD, et al: Chest wall motion in sleep apnea. Am Rev Respir Dis 130:59-63, 1984. 20.Onal E, Lopata M, Ginzburg AS, et al: Diaphragmatic EMG and transdiaphragmatic pressure measurements with a single catheter. Am Rev Respir Dis 124:563-565, 1981. 21.Kreiger A: Assessment of the sleepy patient. In McNicholas WT, Phillipson EA (eds): Breathing Disorders in Sleep. London: WB Saunders, 2002, pp 3-17. 22.Bradley TD, Floras JS (eds): Lung Biology in Health and Disease. Vol 146: Sleep Apnea: Implications in Cardiovascular and Cerebrovascular Disease. New York: Marcel Dekker, 2000. 23.Grunstein RR: Hormonal and metabolic disturbances in sleep apnea. In McNicholas WT, Phillipson EA (eds): Breathing Disorders in Sleep. London: WB Saunders, 2002, pp 209-221. 24.Young T, Peppard PE, Gottlieb DJ: Epidemiology of obstructive sleep apnea. Am J Respir Crit Care Med 165:1217-1239, 2002. 25.Young T, Palta M, Dempsey J, et al: The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328:1230-1235, 1993. 26.Young T, Finn L, Austin D, Peterson A: Menopausal status and sleep-disordered breathing in the Wisconsin Sleep Cohort Study. Am J Respir Crit Care Med 167:1181-1185, 2003. 27.Ancoli-Israel S, Kripke DF, Klauber MR, et al: Sleep disordered breathing in community-dwelling elderly. Sleep 14:486-495, 1991. 28.Young TB, Peppard P: Epidemiology of obstructive sleep apnea. In McNicholas WT, Phillipson EA (eds): Breathing Disorders in Sleep. London: WB Saunders, 2002, pp 31-43. 29.Suratt PM, Dee P, Atkinson RL, et al: Fluoroscopic and computed tomographic features of the pharyngeal airway in obstructive sleep apnea. Am Rev Respir Dis 127:487-492, 1983. 30.Hudgel DW: Variable site of airway narrowing among obstructive sleep apnea patients. J Appl Physiol 61:1403-1409, 1986. 31.Guilleminault C, Stoohs R, Clerk A, et al: Cause of excessive daytime sleepiness: The upper airway resistance syndrome. Chest 104:781-787, 1993. 32.Guilleminault C, Beck J, Carillo O: EEG arousal and upper airway resistance syndrome. Electroencephalogr Clin Neurophysiol 103:501, 1999. 33.Bradley TD, Phillipson EA: Pathogenesis and pathophysiology of the obstructive sleep apnea syndrome. Med Clin North Am 69:1169-1185, 1985. 34.Malhotra A, White DP: Pathogenesis of obstructive sleep apnea syndrome. In McNicholas WT, Phillipson EA (eds): Breathing Disorders in Sleep. London: WB Saunders, 2002, pp 441-463. 35.Remmers JE, de Groot WJ, Sauerland EK, et al: Pathogenesis of upper airway occlusion during sleep. J Appl Physiol 44:931-938, 1978. 36.Smith PL, Wise RA, Gold AR, et al: Upper airway pressure-flow relationships in obstructive sleep apnea. J Appl Physiol 64:789-795, 1988. 37.Schwartz AR, Smith PL, Wise RA, et al: Effect of positive nasal pressure on upper airway pressure-flow relationships. J Appl Physiol 66:1626-1634, 1989. 38.Bear SE, Priest JH: Sleep apnea syndrome: Correction with surgical advancement of the mandible. J Oral Maxillofac Surg 35:543-549, 1980. 39.Mezon BJ, West P, Maclean JP, et al: Sleep apnea in acromegaly. Am J Med 69:615-618, 1980. 40.Orr WC, Martin RJ: Obstructive sleep apnea associated with tonsillar hypertrophy in adults. Arch Intern Med 141:990-992, 1981. 41.Haponik EF, Smith PL, Bohlman ME, et al: Computerized tomography in obstructive sleep apnea. Am Rev Respir Dis 127:221-226, 1983. 42.Riley R, Guilleminault C, Herran J, et al: Cephalometric analyses and flow-volume loops in obstructive sleep apnea patients. Sleep 6:303-311, 1983. 43.Rivlin J, Hoffstein V, Kalbfleisch J, et al: Upper airway morphology in patients with idiopathic obstructive sleep apnea. Am Rev Respir Dis 129:355-360, 1984. 44.Lowe AA, Gionhaker N, Takeuchi K, et al: Three dimensional CT reconstructions of tongue and airway in adult subjects with obstructive sleep apnea. Am J Orthod Dentofacial Orthop 90:364-374, 1986. 45.Horner RL, Mohiaddin RH, Lowell DG, et al: Sites and sizes of fat deposits around the pharynx in obese patients with obstructive sleep apnoea and weight matched controls. Eur Respir J 2:613-622, 1989. 46.Schwab RJ, Pasirstein M, Pierson R, et al: Identification of upper airway anatomic risk factors for obstructive sleep apnea with volumetric magnetic resonance imaging. Am J Respir Crit Care Med 168:522-530, 2003. 47.Davies RJO, Stradling JR: The relationship between neck circumference, radiographic pharyngeal anatomy, and the obstructive sleep apnea syndrome. Eur Respir J 3:509-514, 1990. 48.Issa FG, Sullivan CE: Upper airway closing pressures in obstructive sleep apnea. J Appl Physiol 57:520-527, 1984. 49.Brown IG, Bradley TD, Phillipson EA, et al: Pharyngeal compliance in snoring subjects with and without obstructive sleep apnea. Am Rev Respir Dis 132:211-215, 1985. 50.Bradley TD, Brown IG, Grossman RF, et al: Pharyngeal size in snorers, non-snorers, and patients with obstructive sleep apnea. N Engl J Med 315:1327-1331, 1986. 51.Mezzanotte WS, Tangel DJ, White DP: Waking genioglossal electromyogram in sleep apnea patients versus normal controls (a neuromuscular compensatory mechanism). J Clin Invest 89:1571-1579, 1992. 52.Hendricks JC, Petrof BL, Panckeri K, et al: Compensatory hyperactivity of an upper airway dilator in bulldogs. Am Rev Respir Dis 148:185-194, 1993. 53.Sauerland EK, Harper RM: The human tongue during sleep: Electromyographic activity of the genioglossus muscle. Exp Neurol 51:160-170, 1976. 54.Wheatley JR, Mezzanote WS, Tangel DJ, et al: Influence of sleep on genioglossus muscle activation by negative pressure in normal men. Am Rev Respir Dis 148:597-605, 1993. 55.Onal E, Lopata M, O'Connor T: Pathogenesis of apneas in hypersomnia-sleep apnea syndrome. Am Rev Respir Dis 125:167-174, 1982. 56.Onal E, Lopata M: Periodic breathing and the pathogenesis of occlusive sleep apneas. Am Rev Respir Dis 126:676-680, 1982. 57.Cherniack NS: Sleep apnea and its causes. J Clin Invest 73:150-156, 1984. 58.Hudgel DW, Chapman KR, Faulks C, et al: Changes in inspiratory muscle electrical activity and upper airway resistance during periodic breathing induced by hypoxia during sleep. Am Rev Respir Dis 135:899-906, 1987. 59.Parisi RA, Neubauer JA, Frank MM, et al: Correlation between genioglossal and diaphragmatic responses to hypercapnia during sleep. Am Rev Respir Dis 135:378-382, 1987. 60.Hudgel DW, Harasick T: Fluctuations in timing of upper airway and chest wall inspiratory muscle activity in obstructive sleep apnea. J Appl Physiol 69:443-450, 1990. 61.Taasan VC, Block AJ, Boysen PG, et al: Alcohol increases sleep apnea and oxygen desaturation in asymptomatic men. Am J Med 71:240-245, 1981. 62.Dolly FR, Block AJ: Effect of flurazepam on sleep-disordered breathing and nocturnal oxygen desaturation in asymptomatic subjects. Am J Med 73:239-243, 1982. 63.Issa FG, Sullivan CE: Alcohol, snoring and sleep apnea. J Neurol Neurosurg Psychiatry 45:353-359, 1982. 64.Krol RC, Knuth SL, Bartlett D Jr: Selective reduction of genio-glossal muscle activity by alcohol in normal human subjects. Am Rev Respir Dis 129:247-250, 1984. 65.Martin RJ, Pennock BE, Orr WC, et al: Respiratory mechanics and timing during sleep in occlusive sleep apnea. J Appl Physiol 48:432-437, 1980. 66.Vincken W, Guilleminault C, Silvestri L, et al: Inspiratory muscle activity as a trigger causing the airways to open in obstructive sleep apnea. Am Rev Respir Dis 135:372-377, 1987. 67.Yasuma F, Kozar LF, Kimoff RJ, et al: Interaction of chemical and mechanical respiratory stimuli in the arousal response to hypoxia in sleeping dogs. Am Rev Respir Dis 143:1274-1277, 1991. 68.Bowes G, Townsend ER, Bromley SM, et al: Role of the carotid body and of afferent vagal stimuli in the arousal response to airway occlusion in sleeping dogs. Am Rev Respir Dis 123:644-647, 1981. 69.Sullivan CE, Issa FG, Berthon-Jones M, et al: Pathophysiology of sleep apnea. In Saunders NA, Sullivan CE (eds): Lung Biology in Health and Disease. Vol 21: Sleep and Breathing. New York: Marcel Dekker, 1984, pp 299-363. 70.Bowes G, Woolf GM, Sullivan CE, et al: Effect of sleep fragmentation on ventilatory and arousal responses of sleeping dogs to respiratory stimuli. Am Rev Respir Dis 122:899-908, 1980. 71.Guilleminault C, Rosekind M: The arousal threshold: Sleep deprivation, sleep fragmentation, and obstructive sleep apnea syndrome. Bull Eur Physiopathol Respir 17:341-349, 1981. 72.Flemons WW, Whitelaw WA: Clinical features of obstructive sleep apnea syndrome. In McNicholas WT, Phillipson EA (eds): Breathing Disorders in Sleep. London: WB Saunders, 2002, pp 64-85. 73.George CF, Nickerson PW, Hanly PJ, et al: Sleep apnoea patients have more automobile accidents. Lancet 2:447, 1987. 74.Findley L, Fabrizio M, Thommi G, et al: Severity of sleep apnea and automobile crashes. N Engl J Med 320:868-869, 1989. 75.Barbe F, Pericas J, Munoz A, et al: Automobile accidents in patients with sleep apnea syndrome. Am J Respir Crit Care Med 158:18-22, 1998. 76.Teran-Santos J, Jiminez-Gomez A, Cordero-Guevara J: The association between sleep apnea and the risk of traffic accidents. N Engl J Med 340:847-851, 1999. 77.Telakivi T, Kajaste S, Partinen M, et al: Cognitive function in middle-aged snorers and controls: Role of excessive daytime somnolence and sleep related hypoxic events. Sleep 11:454-462, 1988. 78.Bedard MA, Montplaisir J, Richer F, et al: Obstructive sleep apnea syndrome: Pathogenesis of neuropsychological deficits. Clin Exp Neuropsychol 13:950-964, 1991. 79.Naegele B, Thouvard V, Pepin JL, et al: Deficits of cognitive executive functions in patients with sleep apnea syndrome. Sleep 18:43-52, 1995. 80.Lavie P: Pro: Sleep apnea causes cardiovascular disease. Am J Respir Crit Care Med 169:147-148, 2004. 81.Stradling J: Con: Sleep apnea does not cause cardiovascular disease. Am J Respir Crit Care Med 169:148-149, 2004. 82.Young T, Peppard P, Palta M, et al: Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 157:1746-1752, 1997. 83.Nieto FJ, Young TB, Lind BK, et al: Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 283:1829-1836, 2000. 84.Pepparad PE, Young T, Palta M, et al: Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342:1378-1384, 2000. 85.Kales A, Cadieux RJ, Shaw LC III, et al: Sleep apnoea in a hypertensive population. Lancet 2:1005-1008, 1984. 86.Fletcher ED, DeBehnke RD, Lovoi MS, et al: Undiagnosed sleep apnea in patients with essential hypertension. Ann Intern Med 103:190-195, 1985. 87.Worsnop CJ, Naughton MT, Barter CE, et al: The prevalence of sleep apnea in hypertensives. Am J Respir Crit Care Med 157:111-115, 1998. 88.Logan AG, Perlikowski SM, Mente A, et al: High prevalence of obstructive sleep apnea in drug resistant hypertension. J Hypertens 19:2271-2277, 2001. 89.Shahar E, Whitney CW, Redline S, et al: Sleep-disordered breathing and cardiovascular disease: Cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 163:19-25, 2001. 90.Marin JM, Carrizo SJ, Vicente E et al: Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365:1046-1053, 2005 91.Hedner J, Ejnell H, Sellgren J, et al: Is high and fluctuating muscle nerve sympathetic activity in the sleep apnoea syndrome of pathogenetic importance for the development of hypertension? J Hypertens 6(Suppl 4):S529-S531, 1988. 92.Morgan BJ, Denahan T, Ebert TJ: Neurocirculatory consequences of negative intrathoracic pressure vs. asphyxia during voluntary apnea. J Appl Physiol 74:2969-2975, 1993. 93.Somers VK, Dyken ME, Clary MP, et al: Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96:1897-1904, 1995. 94.Mateika JH, Mateika S, Slutsky AS, et al: The effect of snoring on mean arterial blood pressure during non-REM sleep. Am Rev Respir Dis 145:141-146, 1992. 95.Millman RP, Redline S, Carlisle CC, et al: Daytime hypertension in obstructive sleep apnea: Prevalence and contributing risk factors. Chest 99:861-866, 1991. 96.Fletcher EC, Miller J, Schaaf JW, et al: Urinary catecholamines before and after tracheostomy in patients with obstructive sleep apnea and hypertension. Sleep 10:35-44, 1987. 97.Carlson JT, Hedner J, Elam M, et al: Augmented resting sympathetic nerve activity in awake patients with obstructive sleep apnea. Chest 103:1763-1768, 1993. 98.Narkiewicz K, van de Borne PJ, Cooley RL, et al: Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation 98:772-776, 1998. 99.Ip MS, Lam B, Chan LY, et al: Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med 162:2166-2171, 2000. 100.Imadojemu VA, Gleeson K, Quraishi SA, et al: Impaired vasodilator responses in obstructive sleep apnea are improved with continuous positive airway pressure therapy. Am J Respir Crit Care Med 165:950-953, 2002. 101.Ip MSM, Tse HF, Lam B, et al: Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med 169:348-353, 2004. 102.Nieto FJ, Herrington DM, Redline S, et al: Sleep apnea and markers of vascular endothelial function in a large community sample of older adults. Am J Respir Crit Care Med 169:354-360, 2004. 103.Brooks D, Horner RL, Kozar LF, et al: Obstructive sleep apnea as a cause of systemic hypertension: Evidence from a canine model. J Clin Invest 99:106-109, 1997. 104.Buda AJ, Pinsky MR, Ingels NBJ, et al: Effect of intrathoracic pressure on left ventricular performance. N Engl J Med 301:453-459, 1979. 105.Bradley TD, Holloway RM, McLaughlin PR, et al: Cardiac output response to continuous positive airway pressure in congestive heart failure. Am Rev Respir Dis 145:377-382, 1992. 106.Malone S, Liu PP, Holloway R, et al: Obstructive sleep apnoea in patients with dilated cardiomyopathy: Effects of continuous positive airway pressure. Lancet 338:1480-1484, 1991. 107.Scharf SM, Bianco JA, Tow DE, et al: The effects of large negative intrathoracic pressure on left ventricular function in patients with coronary artery disease. Circulation 63:871-875, 1981. 108.Parker JD, Brooks D, Kozar LF, et al: Acute and chronic effects of airway obstruction on canine left ventricular performance. Am J Respir Crit Care Med 160:1888-1896, 1999. 109.Buda AJ, Schroeder JS, Guilleminault C: Abnormalities of pulmonary artery wedge pressures in sleep-induced apnea. Int J Cardiol 1:67-74, 1981. 110.Peters J, Fraser C, Stuart RS, et al: Negative intrathoracic pressure decreases independently left ventricular filling and emptying. Am J Physiol 257:H120-H131, 1989. 111.Virolainen J, Ventila M, Turto H, et al: Effect of negative intrathoracic pressure on left ventricular pressure dynamics and relaxation. J Appl Physiol 79:455-460, 1995. 112.Hall MJ, Ando SI, Floras JS, et al: Magnitude and time course of hemodynamic responses to Mueller maneuvers in patients with congestive heart failure. J Appl Physiol 85:1476-1484, 1998. 113.Hanly P, Sasson Z, Zuberi N, et al: ST-segment depression during sleep in obstructive sleep apnea. Am J Cardiol 71:1341-1345, 1993. 114.Chaudhary BA, Ferguson DS, Speir WA: Pulmonary edema as a presenting feature of sleep apnea syndrome. Chest 82:122-124, 1982. 115.Chan HS, Chiu HF, Tse LK, et al: Obstructive sleep apnea presenting with nocturnal angina, heart failure, and near-miss sudden death. Chest 99:1023-1025, 1991. 116.Franklin KA, Nilsson JB, Sahlin C: Sleep apnoea and nocturnal angina. Lancet 345:1085-1087, 1995. 117.Cargill RI, Kiely DG, Lipworth BJ: Adverse effects of hypoxemia on diastolic filling in humans. Clin Sci 89:165-169, 1995. 118.Tolle FA, Judy WV, Yu PL, et al: Reduced stroke volume related to pleural pressure in obstructive sleep apnea. J Appl Physiol 55:1718-1724, 1983. 119.Stoohs R, Guilleminault C: Cardiovascular changes associated with obstructive sleep apnea syndrome. J Appl Physiol 72:583-589, 1992. 120.Somers VK, Mark AL, Zavala DC, et al: Contrasting effects of hypoxia and hypercapnia on ventilation and sympathetic activity in humans. J Appl Physiol 67:2101-2106, 1989. 121.Galatius-Jensen S, Hansen J, Rasmussen V, et al: Nocturnal hypoxaemia after myocardial infarction: Association with nocturnal myocardial ischaemia and arrhythmias. Br Heart J 72:23-30, 1994. 122.Shepard JW Jr, Garrison MW, Guther DA, et al: Relationship of ventricular ectopy to nocturnal O2 desaturation in patients with obstructive sleep apnea. Chest 88:325-340, 1985. 123.Daly PA, Sole MJ: Myocardial catecholamines and the pathophysiology of heart failure. Circulation 82(Suppl I):I-35-I-43, 1990. 124.Seppala T, Partinen M, Penttila A, et al: Sudden death and sleeping history among Finnish men. J Intern Med 229:23-28, 1991. 125.Hender J, Ejnell H, Caidahl K: Left ventricular hypertrophy independent of hypertension in patients with obstructive sleep apnea. J Hypertens 8:941-946, 1990. 126.Hanly P, Sasson Z, Zuberi N, et al: Ventricular function in snorers and patients with obstructive sleep apnea. Chest 102:100-105, 1992. 127.Amin R, Kimball T, Bean J, et al: Left ventricular hypertrophy and abnormal ventricular geometry in children and adolescents with obstructive sleep apnea. Am J Respir Crit Care Med 165:1395-1399, 2002. 128.Kaneko Y, Floras JS, Usui K, et al: Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 348:1233-1241, 2003. 129.Mansfield DR, Gollogly NC, Kaye DM, et al: Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med 169:361-366, 2004. 130.Kaye DM, Lambert GM, Lefkovits J, et al: Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure. J Am Coll Cardiol 23:570-578, 1994. 131.Cohn JN, Levine TB, Olivary MT, et al: Plasma norepinephrine as a guide to prognosis in patients with congestive heart failure. N Engl J Med 311:819-823, 1984. 132.Sanner BM, Konermann M, Tepel M, et al: Platelet function in patients with obstructive sleep apnoea syndrome. Eur Respir J 16:648-652, 2000. 133.Bokinsky G, Miller M, Ault K, et al: Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure: A preliminary investigation. Chest 108:625-630, 1995. 134.Nobili L, Schiavi G, Bozano E, et al: Morning increase in whole blood viscosity in obstructive sleep apnea syndrome. Clin Hemorheol Microcirc 22:21-27, 2000. 135.Shamsuzzaman AS, Winnicki M, Lanfranchi P, et al: Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 105:2462-2464, 2002. 136.Schulz R, Mahmoudi S, Hattar K, et al: Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea: Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 162:566-570, 2000. 137.Dyugovskaya L, Lavie P, Lavie L: Increased adhesion molecule expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 165:934-939, 2002. 138.Lavie L, Kraiczi H, Hefetz A, et al: Plasma vascular endothelial growth factor in sleep apnea syndrome: Effects of nasal continuous positive air pressure treatment. Am J Respir Crit Care Med 165:1624-1628, 2002. 139.Ip MS, Lam B, Ng MMT, et al: Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 165:670-676, 2002. 140.Punjabi NM, Sorkin JD, Karzel LI, et al: Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 165:677-682, 2002. 141.Chin K, Shimizu K, Nakamura T, et al: Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 100:706-712, 1999. 142.Harsch IA, Schahin SP, Radespiel-Troger M, et al: Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 169:156-162, 2004. 143.Bradley TD, Rutherford R, Grossman RF, et al: Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome. Am Rev Respir Dis 131:835-839, 1985. 144.Weitzenblum E, Krieger J, Apprill M, et al: Daytime pulmonary hypertension in patients with obstructive sleep apnea syndrome. Am Rev Respir Dis 138:345-349, 1988. 145.Bradley TD, Rutherford R, Lue F, et al: Role of diffuse airway obstruction in the hypercapnia of obstructive sleep apnea. Am Rev Respir Dis 134:920-924, 1986. 146.Garay SM, Rapoport D, Sorkin B, et al: Regulation of ventilation in the obstructive sleep apnea syndrome. Am Rev Respir Dis 124:451-457, 1981. 147.Lopata M, Onal E: Mass loading, sleep apnea, and the pathogenesis of obesity hypoventilation. Am Rev Respir Dis 126:640-645, 1982. 148.. Loube DI, Strohl KP: Obstructive sleep apnea syndrome: Screening and diagnosis. In McNicholas WT, Phillipson EA (eds): Breathing Disorders in Sleep. London: WB Saunders, 2002, pp 86-102. 149.. Whittle AT, Finch SP, Mortimore IL, et al: Use of home sleep studies for diagnosis of the sleep apnoea/hypopnoea syndrome. Thorax 52:1068-1073, 1997. 150.. Hoffstein V: Is snoring dangerous to your health? Sleep 19:506-516, 1996. 151.. Braver HM, Block AJ, Perri MG: Treatment for snoring: Combined weight loss, sleeping on the side, and nasal spray. Chest 107:1283-1288, 1995. 152.. American Thoracic Society: Indications and standards for use of nasal continuous positive airway pressure (CPAP) in sleep apnea syndromes. Am J Respir Crit Care Med 150:1738-1745, 1994. 153.. Lévy P, Pépin JL: Management options in obstructive sleep apnea syndrome. In McNicholas WT, Phillipson EA (eds): Breathing Disorders in Sleep. London: WB Saunders, 2002, pp 105-115. 154.. Hoffstein V: Clinical significance and management of snoring without obstructive sleep apnea syndrome. In McNicholas WT, Phillipson EA (eds): Breathing Disorders in Sleep. London: WB Saunders, 2002, pp 164-178. 155.. O'Sullivan RA, Hillman DR, Mateljan R, et al: Mandibular advancement splint: An appliance to treat snoring and obstructive sleep apnea. Am J Respir Crit Care Med 151:194-198, 1995. 156.. Ferguson KA, Ono T, Lowe A, et al: A randomized cross-over trial of an oral appliance vs. nasal continuous positive airway pressure in the treatment of mild-moderate obstructive sleep apnea. Chest 109:1269-1275, 1996. 157.. Stradling JR, Negus TW, Smith D, et al: Mandibular advancement devices for the control of snoring. Eur Respir J 11:447-450, 1998. 158.. Engleman HE, Kingshott RN, Wraith PK, et al: Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 159:461-467, 1999. 159.. Fujita S, Conway W, Zorick F, et al: Surgical correction of anatomic abnormalities in obstructive sleep apnea syndrome: Uvulopalatopharyngoplasty. Otolaryngol Head Neck Surg 89:923-934, 1981. 160.. Kamami YV: Laser CO2 for snoring: Preliminary results. Acta Otorhinolaryngol Belg 44:451-456, 1990. 161.. Schmidt-Nowara WW, Meade TE, Hays MB: Treatment of snoring and obstructive sleep apnea with a dental orthosis. Chest 99:1378-1385, 1991. 162.. Ng AT, Gotsopoulos H, Qian J, Cistulli PA: Effect of oral appliance therapy on upper airway collapsibility in obstructive sleep apnea. Am J Respir Crit Care Med 168:238-241, 2003. 163. Sher AE, Schechtman KB, Piccirillo JF: The efficacy of surgical modifications of the upper airway in adults with obstructive sleep apnea syndrome. Sleep 19:156-177, 1996. 164.. Ryan CF, Lowe AA, Li D, et al: Three dimensional upper airway computed tomography in obstructive sleep apnea: A prospective study in patients treated by uvulopalatopharyngoplasty. Am Rev Respir Dis 144:428-432, 1991. 165.. Launois SH, Feroah TR, Campbell WN, et al: Site of pharyngeal narrowing predicts outcome of surgery for obstructive sleep apnea. Am Rev Respir Dis 147:182-189, 1993. 166.. Sullivan CE, Issa FG, Berthon-Jones M, et al: Reversal of obstructive sleep apnea by continuous positive airway pressure applied through the nares. Lancet 1:862-865, 1981. 167.. Sullivan CE, Issa FG, Berthon-Jones M, et al: Home treatment of obstructive sleep apnea with continuous positive airway pressure applied through a nose-mask. Bull Eur Physiopathol Respir 20:49-54, 1984. 168.. Hoffstein V, Viner S, Mateika S, et al: Treatment of obstructive sleep apnea with nasal continuous positive airway pressure: Patient compliance, perception of benefits, and side effects. Am Rev Respir Dis 145:841-845, 1992. 169.. McNicholas WT: Nasal continuous positive airway pressure therapy for obstructive sleep apnea syndrome. In McNicholas WT, Phillipson EA (eds): Breathing Disorders in Sleep. London: WB Saunders, 2002, pp 116-133. 170.. Becker HF, Jerrentrup A, Ploch T, et al: Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 107:68-73, 2003. 171.Logan AG, Tkacova R, Perlikowski SM, et al: Refractory hypertension and sleep apnea: Effect of CPAP on blood pressure and baroreflex. Eur Respir J 21:241-247, 2003. 172.. Weitzman ED, Kahn E, Pollack CP: Quantitative analysis of sleep and sleep apnea before and after tracheostomy in patients with the hypersomnia-sleep apnea syndrome. Sleep 3:407-423, 1980. 173.. Guilleminault C, Simmons FB, Motta J, et al: Obstructive sleep apnea syndrome and tracheostomy: Long-term followup experience. Arch Intern Med 141:985-988, 1981. 174.Bradley TD, Phillipson EA: Central sleep apnea. Clin Chest Med 13:493-505, 1992. 175.. Bradley TD, McNicholas WT, Rutherford R, et al: Clinical and physiologic heterogeneity of the central sleep apnea syndrome. Am Rev Respir Dis 134:217-221, 1986. 176.Orem J: The nature of the wakefulness stimulus to breathing. Prog Clin Biol Res 345:23-31, 1990. 177.. McNicholas WT, Phillipson EA: Central hypoventilation syndromes and hypercapnic central sleep apnea. In McNicholas WT, Phillipson EA (eds): Breathing Disorders in Sleep. London: WB Saunders, 2002, pp 239-245. 178.. Bradley TD: Nonhypercapnic central sleep apnea. In McNicholas WT, Phillipson EA (eds): Breathing Disorders in Sleep. London: WB Saunders, 2002, pp 246-264. 179.. Phillipson EA: Control of breathing during sleep. Am Rev Respir Dis 118:909-939, 1978. 180.Khoo MCK, Kronauer RE, Strohl KP, et al: Factors inducing periodic breathing in humans: A general model. J Appl Physiol 53:644-659, 1982. 181.. Skatrud JB, Dempsey JA: Interaction of sleep state and chemical stimuli in sustaining rhythmic ventilation. J Appl Physiol 55:813-822, 1983. 182.186. Datta AK, Shea SA, Horner RL, et al: The influence of induced hypocapnia and sleep on the endogenous respiratory rhythm in humans. J Physiol (Lond) 440:17-33, 1991. 183.187. Khoo MCK, Gottschalk A, Pack AI: Sleep-induced periodic breathing and apnea: A theoretical study. J Appl Physiol 70:2014-2024, 1991. 184.Berssenbrugge A, Dempsey J, Iber C, et al: Mechanisms of hypoxia-induced periodic breathing during sleep in humans. J Physiol (Lond) 343:507-524, 1983. 185.. Lahiri S, Maret K, Sherpa MG: Dependence of high altitude sleep apnea on ventilatory sensitivity to hypoxia. Respir Physiol 52:281-301, 1983. 186.. Weil JV: Sleep at high altitude. Clin Chest Med 6:615-621, 1985. 187.. Javaheri S, Parker TJ, Liming JD, et al: Sleep apnea in 81 ambulatory male patients with stable heart failure. Circulation 97:2154-2159, 1998. 188.. Sin DD, Fitzgerald F, Parker JD, et al: Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 160:1101-1106, 1999. 189.. Naughton M, Benard D, Tam A, et al: Role of hyperventilation in the pathogenesis of central sleep apneas in patients with congestive heart failure. Am Rev Respir Dis 148:330-338, 1993. 190.. Lorenzi-Filho G, Rankin F, Bies I, et al: Effects of inhaled carbon dioxide and oxygen on Cheyne-Stokes respiration in patients with heart failure. Am J Respir Crit Care Med 159:1490-1498, 1999. 191.. Xie A, Wong B, Phillipson EA, et al: Interaction of hyperventilation and arousal in the pathogenesis of idiopathic central sleep apnea. Am J Respir Crit Care Med 150:489-495, 1994. 192.. Javaheri S: A mechanism of central sleep apnea in patients with heart failure. N Engl J Med 341:949-954, 1999. 193.. Tkacova R, Hall MJ, Liu PP, et al: Left ventricular volume in patients with heart failure and Cheyne-Stokes respiration during sleep. Am J Respir Crit Care Med 156:1549-1555, 1997. 194.Solin P, Bergin P, Richardson M, et al: Influence of pulmonary capillary wedge pressure on central apnea in heart failure. Circulation 99:1574-1579, 1999. 195.Solin P, Roebuck T, Johns DP, et al: Peripheral and central ventilatory responses in central sleep apnea with and without congestive heart failure. Am J Respir Crit Care Med 162:2194-2200, 2000. 196.. Churchill ED, Cope O: The rapid shallow breathing resulting from pulmonary congestion and edema. J Exp Med 49:531-537, 1929. 197.Xie A, Rankin F, Rutherford R, et al: Effects of inhaled CO2 and added dead space on idiopathic central sleep apnea. J Appl Physiol 82:918-926, 1997. 198.Naughton MT, Liu PP, Bernard DC, et al: Treatment of congestive heart failure and Cheyne-Stokes respiration during sleep by continuous positive airway pressure. Am J Respir Crit Care Med 151:92-97, 1995. 199.van de Borne P, Oren R, Abouassaly C, et al: Effect of Cheyne-Stokes respiration on muscle sympathetic nerve activity in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 81:432-436, 1998. 200.Naughton MT, Benard DC, Liu PP, et al: Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med 152:473-479, 1995. 201.Bradley TD: Right and left ventricular functional impairment and sleep apnea. Clin Chest Med 13:459-479, 1992. 202.Harrison TR, King CE, Calhoun JA, et al: Cheyne-Stokes respiration as the cause of paroxysmal dyspnea at the onset of sleep. Arch Intern Med 53:891-910, 1934. 203.Hanly PJ, Millar TW, Steljes DG, et al: Respiration and abnormal sleep in patients with congestive heart failure. Chest 96:480-488, 1989. 204.Dowdell WT, Javaheri S, McGinnis W: Cheyne-Stokes respiration presenting as sleep apnea syndrome: Clinical and polysomnographic features. Am Rev Respir Dis 141:871-879, 1990. 205.. Javaheri S, Corbett WS: Association of low PaCO2 with central sleep apnea and ventricular arrhythmias in ambulatory patients with stable heart failure. Ann Intern Med 128:204-207, 1998. 206.Goldman S, Johnson G, Cohn JN, et al: Mechanism of death in heart failure: The vasodilator-heart failure trials. Circulation 87(Suppl VI):VI-24-VI-31, 1993. 207.. Hanly PJ, Zuberi-Khokhar NS: Increased mortality associated with Cheyne-Stokes respiration in patients with congestive heart failure. Am J Respir Crit Care Med 153:272-276, 1996. 208.Sutton FD Jr, Zwillich CW, Creagh CE, et al: Progesterone for outpatient treatment of Pickwickian syndrome. Ann Intern Med 83:476-479, 1975. 209.Bubis MJ, Anthonisen NR: Primary alveolar hypoventilation treated by nocturnal administration of O2. Am Rev Respir Dis 118:947-953, 1978. 210.Barlow PB, Bartlett D Jr, Hauri P, et al: Idiopathic hypoventilation syndrome: Importance of preventing nocturnal hypoxemia and hypercapnia. Am Rev Respir Dis 121:141-145, 1980. 211.. Farmer WC, Glenn WWL, Gee JBL: Alveolar hypoventilation syndrome: Studies of ventilatory control in patients selected for diaphragm pacing. Am J Med 64:39-49, 1978. 212.Garay SM, Turino GM, Goldring RM: Sustained reversal of chronic hypercapnia in patients with alveolar hypoventilation syndromes. Am J Med 70:269-274, 1981. 213.. Goldstein RS, Molotiu N, Skrastins R, et al: Reversal of sleep-induced hypoventilation and chronic respiratory failure by nocturnal negative pressure ventilation in patients with restrictive ventilatory impairment. Am Rev Respir Dis 135:1049-1055, 1987. 214.Ellis ER, Bye PTP, Bruderer JW, et al: Treatment of respiratory failure during sleep in patients with neuromuscular disease: Positive pressure ventilation through a nose mask. Am Rev Respir Dis 135:148-152, 1987. 215.. Bach JR, Alber AS: Management of chronic alveolar hypoventilation by nasal ventilation. Chest 97:52-57, 1990. 216.Goldstein RS, Avendano MA, DeRosie JA, et al: Influence of non-invasive positive pressure ventilation on inspiratory muscles. Chest 99:408-415, 1991. 217.. Martin RJ, Sanders MH, Gray BA, et al: Acute and long-term ventilatory effects of hypoxia in the adult sleep apnea syndrome. Am Rev Respir Dis 125:175-180, 1982. 218.White DP, Zwillich CW, Pickett CK, et al: Central sleep apnea: Improvement with acetazolamide therapy. Arch Intern Med 142:1816-1819, 1982. 219.Issa FG, Sullivan CE: Reversal of central sleep apnea using nasal CPAP. Chest 90:165-171, 1986. 220.Hoffstein V, Slutsky AS: Central sleep apnea reversed by continuous positive airway pressure. Am Rev Respir Dis 135:1210-1212, 1987. 221.. Bradley TD, Holloway R, McLaughlin P, et al: Cardiac output response to continuous positive airway pressure in congestive heart failure. Am Rev Respir Dis 145:377-382, 1992. 222.Tkacova R, Liu PP, Naughton MT, et al: Effect of continuous positive airway pressure on mitral regurgitant fraction and atrial natriuretic peptide in patients with heart failure. J Am Coll Cardiol 30:739-745, 1997. 223.Naughton MT, Bradley TD: Sleep apnea in congestive heart failure. Clin Chest Med 19:99-113, 1998. document: $pr: version: 01-2007.1 codepage: windows-1251 type: klinrek id: kli40012824 : 15.3. ПСИХИЧЕСКИЕ РАССТРОЙСТВА У БОЛЬНЫХ С ЛЕГОЧНОЙ ПАТОЛОГИЕЙ meta: author: fio[ru]: А.Б. Смулевич, С.И. Овчаренко, М.Ю. Дробижев codes: next: type: dklinrek code: III.X type: dkli00182 Дата добавления: 2015-01-18 | Просмотры: 1103 | Нарушение авторских прав |